We use cookies to make sure that our website works properly, as well as some optional cookies to personalize content and advertising, provide social media features and analyse how people use our site. Some countries outside of the European Economic Area do not have the same data protection standards as the country where you live, so if you accept some or all optional cookies, you give consent to the processing of your personal data, including transfer to third parties. You can find more information about how your personal data is processed when you click on theManage settings. Further information can be found in our privacy policy.

SARS-CoV-2 is associated with changes in brain structure in UK Biobank
  • Gwenaëlle Douaud  orcid.org/0000-0003-1981-391X1,
  • Soojin Lee1,
  • Fidel Alfaro-Almagro1,
  • Christoph Arthofer  orcid.org/0000-0003-1474-99631,
  • Chaoyue Wang  orcid.org/0000-0001-9402-15631,
  • Paul McCarthy1,
  • Frederik Lange  orcid.org/0000-0002-1736-71621,
  • Jesper L. R. Andersson1,
  • Ludovica Griffanti1,2,
  • Eugene Duff1,3,
  • Saad Jbabdi1,
  • Bernd Taschler  orcid.org/0000-0001-6574-47891,
  • Peter Keating4,
  • Anderson M. Winkler5,
  • Rory Collins6,
  • Paul M. Matthews  orcid.org/0000-0002-1619-83287,
  • Naomi Allen6,
  • Karla L. Miller1,
  • Thomas E. Nichols  orcid.org/0000-0002-4516-51038 &
  • Stephen M. Smith  orcid.org/0000-0001-8166-069X1 

This article is about Nature.

  • 71k accesses.

  • 8071 is a Altmetric.

  • There are metrics.

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

There is strong evidence for brain-related abnormality. It's not known if the impact of the disease can be detected in milder cases or if it can reveal mechanisms that contribute to brain pathology. We studied brain changes in 785 UK Biobank participants who were imaged twice, and found that many of them had positive tests for the disease between their first and second scans. Pre-existing risk factors are less likely to be misinterpreted as disease effects if the data is available. There were significant longitudinal effects when comparing the two groups, including greater reduction in grey matter thickness and tissue-contrast in the orbitofrontal cortex and parahippocampal gyrus. Between the two timepoints, the participants with the infections showed larger cognitive decline. The effects were still seen after the 15 cases who had been hospitalized were excluded. The results of brain scans may be indicative of the spread of the disease via olfactory pathways, or of the loss of sensory input due to anosmia. The effects of this impact are still being investigated, whether they can be partially reversed or if they will persist in the long term.

Supplementary Discussion and additional references are included in the file, as well as Supplementary Longitudinal Plots, Supplementary Baseline Plots, Supplementary Analyses and additional references.

There is a full list of IDPs used in the hypothesis-driven and exploratory approaches.

There is a full list of IDPs used in the hypothesis-driven and exploratory approaches.

There is a full list of IDPs used in the hypothesis-driven and exploratory approaches.

The full list of non-IDPs is used for the cross-sectional, baseline comparison between the two groups.

There is a full list of IDPs used in the hypothesis-driven and exploratory approaches.

You agree to abide by the Community Guidelines when you submit a comment. If you find something that does not comply with our guidelines, please flag it as inappropriate.